Patent details

EN | LT

LT - CRYSTALLINE FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)

EN - CRYSTALLINE FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 207/34
		A61K 31/40
		A61P 3/06
		A61P 25/28

European patent
(11)	Number of the document	1423364
(13)	Kind of document	T
(96)	European patent application number	02727946.2
	Date of filing the European patent application	2002-05-21
(97)	Date of publication of the European application	2004-06-02
(45)	Date of publication and mention of the grant of the patent	2015-11-04
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IB2002/001796
	Date	2002-05-21

PCT application publication
(87)	Number	WO 2003/004470
	Date	2003-01-16

Priority applications
(30)	Number	Date	Country code
	302049 P	2001-06-29	US

Inventors
(72)	BYRN, Stephen Robert, US COATES, David Andrew, US GUSHURST, Karen Sue, US MORRISON, Henry Grant, II, US PARK, Aeri, US VLAHOVA, Petinka Ivanova, US LI, Zheng J., Pfizer Global Research and Develop., US KRZYZANIAK, J. F., Pfizer Global Researchand Dev., US

Grantee
(73)	Warner-Lambert Company LLC, 235 East 42nd Street, New York, NY 10017, US

Title
(54)	CRYSTALLINE FORMS OF [R-(R,R)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)
	CRYSTALLINE FORMS OF [R-(R,R)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)